Thank you, Phillips Kuhl - #DELFI is excited for our Chief Scientific Officer, Nicholas Dracopoli- to join the panel providing insights on unmet needs, practical recommendations for test development, and case studies at the Cambridge Healthtech Institute's 16th Annual Next Generation Dx Summit this August. To learn more about the Summit, please visit: https://bit.ly/3A1bH45 #cancerresearch #earlycancersurveillance #NGDx #biomarkers #earlydetection #genomics
Dive into the depths of early cancer surveillance at the Next Generation Dx Summit this August. https://lnkd.in/e2d9xRZH Hear from leaders at Mercy BioAnalytics, Inc., Guardant Health, and Geneoscopy on work geared towards improving single cancer detection. Speakers Dawn Mattoon, Craig Eagle, and Erica Barnell will go over the clinical data and ongoing test development. Later, we will hear from Tomasz (Tom) Beer at Exact Sciences, HsianRong Tseng at UCLA, and Jimmy ChengHo Lin at Freenome on innovating multi-cancer early detection technologies by leveraging multiomics and machine learning. The program will then hone in on sequence-based MCEDs with talks from Megan P. Hall at GRAIL, Alexey Aleshin at Natera, Hutan Ashrafian at Harbinger Health, and Nicholas Dracopoli at DELFI Diagnostics. This concluding session will provide insights on meeting unmet detection needs, practical recommendations for test development, and case studies. Visit our website to see the full program details and so you don’t miss out on cutting edge research. #NGDx #biomarkers #earlydetection #omics #cancerresearch